Pura Vida Investments, LLC Lyra Therapeutics, Inc. Transaction History

Pura Vida Investments, LLC

$140 Million
Q1 2024

A detailed history of Pura Vida Investments, LLC transactions in Lyra Therapeutics, Inc. stock. As of the latest transaction made, Pura Vida Investments, LLC holds 1,413,242 shares of LYRA stock, worth $395,707. This represents 6.26% of its overall portfolio holdings.

Number of Shares

1,413,242

Previous 1,413,242 -0.0%

Holding current value

$395,707

Previous $7.41 Million 18.7%

% of portfolio

6.26%

Previous 2.51%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$1.98 - $4.33 $1.16 Million - $2.53 Million	-583,730 Reduced 29.23%	1,413,242 $5.81 Million
Q1 2023 May 15, 2023	SELL	$1.95 - $3.09 $312,635 - $495,407	-160,326 Reduced 7.43%	1,996,972 $4.01 Million
Q4 2022 Feb 14, 2023	SELL	$2.44 - $4.92 $861,329 - $1.74 Million	-353,004 Reduced 14.06%	2,157,298 $6.77 Million
Q3 2022 Nov 14, 2022	SELL	$5.33 - $6.6 $351,215 - $434,900	-65,894 Reduced 2.56%	2,510,302 $12.6 Million
Q2 2022 Aug 15, 2022	BUY	$4.12 - $7.51 $8.47 Million - $15.4 Million	2,055,652 Added 394.9%	2,576,196 $14.6 Million

Q1 2022 May 16, 2022	BUY	$3.5 - $5.36 $11,550 - $17,688	3,300 Added 0.64%	520,544 $2.09 Million
Q4 2021 Feb 14, 2022	SELL	$4.22 - $9.41 $68,250 - $152,187	-16,173 Reduced 3.03%	517,244 $2.26 Million
Q3 2021 Nov 15, 2021	SELL	$6.06 - $9.43 $55,915 - $87,010	-9,227 Reduced 1.7%	533,417 $4.87 Million
Q2 2021 Aug 16, 2021	BUY	$6.91 - $12.59 $3.75 Million - $6.83 Million	542,644 New	542,644 $4.36 Million
Q4 2020 Feb 16, 2021	SELL	$9.28 - $13.88 $2.1 Million - $3.15 Million	-226,703 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.61 - $13.96 $304,422 - $400,540	28,692 Added 14.49%	226,703 $2.54 Million
Q2 2020 Aug 14, 2020	BUY	$10.91 - $18.56 $2.16 Million - $3.68 Million	198,011 New	198,011 $2.25 Million

Others Institutions Holding LYRA

# of Institutions

Shares Held

44.4M

Call Options Held

300K

Put Options Held

1.3K

View Full List

About Lyra Therapeutics, Inc.

Ticker LYRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,826,400
Market Cap $8.91M
Description
Lyra Therapeutics, Inc., a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained...

More about LYRA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.

Account

Pura Vida Investments, LLC Lyra Therapeutics, Inc. Transaction History